Alps Advisors Inc Praxis Precision Medicines, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.75 - $11.34 $81,807 - $530,110	-46,747 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $52,683 - $104,696	-5,160 Reduced 9.94%	46,747 $477,000
Q4 2021 Feb 09, 2022	SELL	$16.76 - $22.99 $52,559 - $72,096	-3,136 Reduced 5.7%	51,907 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$13.15 - $22.56 $31,717 - $54,414	-2,412 Reduced 4.2%	55,043 $1.02 Million
Q2 2021 Aug 11, 2021	BUY	$18.28 - $33.05 $1.05 Million - $1.9 Million	57,455 New	57,455 $1.05 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.02B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.